Gregory J. Panzarella

Gregory J. Panzarella's patent litigation practice, primarily operating through Panzarella & Associates, centers on defending clients in complex intellectual property disputes. His known experience includes representing defendants in pharmaceutical patent infringement actions.

In his tracked appearance, Mr. Panzarella served as local counsel for Zydus Pharmaceuticals (USA) Inc. in the Hatch-Waxman litigation Astellas Pharma Inc. et al. v. Zydus Pharmaceuticals (USA) Inc. et al. This case involved U.S. patents protecting mirabegron extended-release oral tablet formulations, used to treat overactive bladder. The litigation concluded with a consent judgment where Zydus stipulated to the validity, enforceability, and infringement of Astellas's patents related to generic mirabegron products.

Beyond this specific case, further details regarding Mr. Panzarella's broader patent litigation portfolio, including other technology areas, notable trial outcomes, or appearances in PTAB/IPR proceedings, are not widely available through public web searches. Similarly, information regarding his specific bar admissions and educational background could not be reliably sourced from the available public records.